Accessibility Menu
MedSmart Group logo

MedSmart Group(OTC) MSGP

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2005)-100%
5 Year-100%
1 Year+500%
1 Month+0%
$0.00
+0%
+0.00Today
MedSmart Group last closing stock price
MetricPriceDate
Last closeUSD 0.002026-07-27
MedSmart Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-07-15
1 month+0%USD 0.002026-06-26
3 month+0%USD 0.002026-04-28
Year to date+20%USD 0.002025-12-26
1 year+500%USD 0.002025-07-24
3 year+20%USD 0.002023-07-28
5 year-99.95%USD 1.332021-07-28
Since inception-100%USD 120,000.002005-08-17

MedSmart Group Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$126.03K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

22.37 (High)

Price

$0.00

Volume

450

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

MSGP News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About MedSmart Group

MedSmart Group Inc. operates a network of wellness centers focused on anti-aging solutions. The company offers a range of services including hormone replacement therapies and various health treatments.

Products and Services
  • Hormone replacement therapies, including testosterone and general hormone restoration
  • Cryogen therapy and treatments for health issues like diabetes and hypertension
  • Aesthetic procedures such as laser hair removal and vein treatment
Growth Outlook
  • Expansion of wellness centers to meet increasing demand for anti-aging solutions
  • Growing awareness of health and wellness trends among consumers
  • Potential for new service offerings to enhance revenue streams
Financial Highlights
  • Recent quarterly net income of -$36,699, indicating ongoing operational challenges
  • Trailing twelve months (TTM) revenue remains at $0, highlighting the need for strategic growth
  • Current liabilities significantly exceed current assets, indicating liquidity concerns
MedSmart Group Inc. is positioned in the healthcare sector, specifically within medical care facilities. The company’s focus on anti-aging solutions aligns with growing consumer interest in health and wellness. Despite recent financial challenges, including a net income loss and zero revenue, the potential for growth exists through the expansion of services and increased consumer awareness. The company's operational strategy may need to adapt to improve financial performance and capitalize on market opportunities.
AI Generated • Jul 28, 2026

Industry

Healthcare Providers and Services

CEO

Calvin Lewis

Headquarters

Bay Harbor Islands, FL 33154, US

MSGP Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

26.84%

Return on Capital

-13.80%

Return on Assets

-10.14%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

0

Volume

450

Avg. Volume

101

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$134.72K

EBITDA

-$107.64K

Operating Cash Flow

-$127.15K

Capital Expenditure

$0.00

Free Cash Flow

-$127.15K

Cash & ST Invst.

$0.00

Total Debt

$221.92K

MedSmart Group Performance Analysis

MedSmart Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 0N/A
MedSmart Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42021-12-31N/A
Q12022-03-31N/A
Q22022-06-30N/A
Q32022-09-30N/A
MedSmart Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -0.00N/A
MedSmart Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42021-12-31-20.0%
Q12022-03-3116.7%
Q22022-06-30-20.0%
Q32022-09-30-16.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2022YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

4

N/A

Net Income

-$36.70K

-86.5%

EBITDA

-$5.93K

+66.8%

Quarterly Fundamentals

Name
Q3 2022YOY CHG

Total Cash

$0.00

N/A

Total Debt

$221.92K

+19802.2%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$221.92K

+19802.2%

Return on Assets

-10.14%

N/A

Return on Invested Capital

-28.11%

N/A

Free Cash Flow

-$23.75K

-935.0%

Operating Cash Flow

-$23.75K

-935.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SCIESpectraScience, Inc.
$0.00+0.00%
IYXIInyx, Inc.
$0.00+0.00%
INNDInnerScope Hearing Technologies, Inc.
$0.00+0.00%
BTTXBetter Therapeutics, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares
$19.63-0.20%
NOKNokia
$8.41-0.06%
SKHYSK Hynix
$126.79-0.03%
TQQQProShares Trust - ProShares UltraPro Qqq
$57.75-0.06%

Questions About MSGP

What is the current price of MedSmart Group?

MedSmart Group is trading at $0.00 per share.

What is the 52-week range for MedSmart Group?

Over the past 52 weeks, MedSmart Group has traded between $0.00 and $0.00.

How much debt does MedSmart Group have?

As of the most recent reporting period, MedSmart Group reported total debt of $70.00K.

How much cash does MedSmart Group have on hand?

MedSmart Group reported $0.00 in cash and cash equivalents in its most recent financial results.

What is MedSmart Group’s dividend yield?

MedSmart Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.